Gilead Sciences (GILD) Tax Rate (2009 - 2026)
Gilead Sciences' (GILD) quarterly Tax Rate came in at 21.67% in Q1 2026, up 141.0% YoY from 8.99% in Q1 2025, and up 200.05% on a QoQ basis from 21.66% in Q4 2025.
Gilead Sciences (GILD) Tax Rate (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has 18 years of Tax Rate data on file, last reported at 21.67% in Q1 2026.
- Quarterly Tax Rate rose 141.0% year-over-year to 21.67% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10.87% (down 173.0% YoY) and the FY2025 annual result came in at 13.13%, down 1745.0% from the prior year.
- Tax Rate rose to 21.67% in Q1 2026, from 21.66% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 107.89% in Q1 2022 to a low of 31.07% in Q3 2024.
- A 5-year average of 19.34% and a median of 19.6% in 2022 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2022 — Tax Rate soared 8395 bps — and 2023, when it slumped 8359 bps.
- Tracing GILD's Tax Rate over 5 years: stood at 19.6% in 2022, then dropped by 27 bps to 14.34% in 2023, then increased by 24 bps to 17.77% in 2024, then plunged by 222 bps to 21.66% in 2025, then jumped by 200 bps to 21.67% in 2026.
- The last three Tax Rate figures came in at 21.67% (Q1 2026), 21.66% (Q4 2025), and 16.18% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.81 Bn | 633.06 Bn | 17.26 Bn | 17.98% |
| 2 | AbbVie | 469.85 Bn | 463.28 Bn | 12.70 Bn | 15.47% |
| 3 | Merck | 375.13 Bn | 367.99 Bn | 12.21 Bn | -95.75% |
| 4 | Novartis Ag | 302.67 Bn | 294.98 Bn | 11.24 Bn | 23.71% |
| 5 | Astrazeneca | 257.60 Bn | 252.70 Bn | 12.86 Bn | 10.40% |
| 6 | Amgen | 237.08 Bn | 223.09 Bn | 7.24 Bn | 14.20% |
| 7 | Gilead Sciences | 183.35 Bn | 180.18 Bn | 6.22 Bn | -2.36% |
| 8 | Pfizer | 160.17 Bn | 148.47 Bn | 10.94 Bn | 62.33% |
| 9 | Gsk | 105.99 Bn | 101.83 Bn | 8.24 Bn | 56.21% |
| 10 | Sanofi | 55.21 Bn | 47.83 Bn | 10.79 Bn | -3.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.36% |
| Jun 30, 2026 | -2.36% |
| Jun 30, 2026 | -2.36% |
| Mar 31, 2026 | 21.67% |
| Mar 31, 2026 | 21.67% |
| Mar 31, 2026 | 21.67% |
| Dec 31, 2025 | -21.66% |
| Dec 31, 2025 | -21.66% |
| Dec 31, 2025 | -21.66% |
| Sep 30, 2025 | 16.18% |
| Sep 30, 2025 | 16.18% |
| Sep 30, 2025 | 16.18% |
| Jun 30, 2025 | 19.27% |
| Jun 30, 2025 | 19.27% |
| Jun 30, 2025 | 19.27% |
| Mar 31, 2025 | 20.25% |
| Mar 31, 2025 | 20.25% |
| Mar 31, 2025 | 20.25% |
| Dec 31, 2024 | 17.77% |
| Dec 31, 2024 | 17.77% |